Skip to main content
Veterinary Medicines

HIPRAVIAR-S/H120 lyofilizát na suspenziu pre kurčatá

Authorised
  • Newcastle disease virus, strain La Sota, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Product identification

Medicine name:
HIPRAVIAR-S/H120 lyofilizát na suspenziu pre kurčatá
Active substance:
  • Newcastle disease virus, strain La Sota, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • In drinking water use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Live
    6.50
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.00
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • All relevant tissues
        0
        day
  • In drinking water use
    • Chicken
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/128/04-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 13/12/2021